Now On Demand! The Tumor Inflammation Signature and Composite Biomarkers for Patient Stratification for Immunotherapy



Join us for a webinar discussing Tumor Inflammation Signature (TIS) gene signature development and validation. Senior Scientist, Translational Science & Pathology, Dr. Sarah Church, will share the latest developments in TIS utility for immunotherapy clinical studies and, TIS correlation to other biomarkers, and use of TIS in composite biomarker testing programs for Immunotherapy. Stick around for live Q&A with the speaker!

Session Highlights

  • Overview of the Tumor Inflammation Signature (TIS)
  • TIS utility for clinical trials
  • TIS and treatment effect
  • TIS correlation to other biomarkers
  • Use of TIS in composite biomarker strategies for immunotherapy
  • Live Q&A


Sarah Church, PhD
Senior Scientist, Translational Science & Pathology
NanoString Technologies